Study protocol for the COPE study: COVID-19 in Older PEople: the influence of frailty and multimorbidity on survival. A multicentre, European observational study
Thomas Lee,
Sandeep Singh,
Phyo Kyaw Myint,
Sheila Jones,
Ben Carter,
Susan Moug,
Terry Quinn,
Michael Thomas,
Emma Bhatti,
Angeline Price,
Fenella Barlow-Pay,
Siobhan Duffy,
Lyndsay Pearce,
Arturo Vilches-Moraga,
Michael Stechman,
Philip Braude,
Emma Mitchell,
Alessia Verduri,
Kathryn McCarthy,
Jonathan Hewitt,
Charlotte Davey,
Kiah Lunstone,
Alice Cavenagh,
Charlotte Silver,
Thomas Telford,
Rebecca Simmons,
Dolcie Paxton,
Francis Rickard,
Mark Holloway,
James Hesford,
Tarik Jichi,
Norman Galbraith,
Jenny Edwards,
Carly Bisset,
Ross Alexander,
Abigail Ingham,
Roxanna Short,
Aine McGovern,
Jemima Collins,
Eilidh Bruce,
Alice Einarsson,
Enrico Clini,
Giovanni Guaraldi,
Madeline Garcia,
Shefali Sangani,
Thomas Kneen,
George Kyriakopoulos,
Denise Tan
Affiliations
Thomas Lee
Sandeep Singh
Cardiology, Cardio-Thoracic Sciences Centre, All India Institute of Medical Sciences, New Delhi, Delhi, India
Phyo Kyaw Myint
Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
Sheila Jones
Ben Carter
Wellcome Trust Clinical Training Fellow, Division of Psychiatry, University College London
Susan Moug
4 Royal Alexandra Hospital, Paisley, UK
Terry Quinn
School of Cardiovascular and Medical Sciences, University of Glasgow College of Medical Veterinary and Life Sciences, Glasgow, UK
Michael Thomas
2 Department of Thoracic Oncology, Thoraxklinik-Heidelberg gGmbH, Heidelberg, Baden-Württemberg, Germany
Emma Bhatti
Anaesthetics, Royal Alexandra Hospital, Paisley, UK
Angeline Price
Ageing and Complex Medicine, Salford Royal NHS Trust, Salford, UK
Fenella Barlow-Pay
Department of Anaesthetics, Royal Alexandra Hospital, Paisley, Renfrewshire, UK
Siobhan Duffy
General Surgery, Royal Alexandra Hospital, Paisley, Renfrewshire, UK
Lyndsay Pearce
General Surgery, Salford Royal NHS Foundation Trust, Salford, UK
Arturo Vilches-Moraga
Ageing and Complex Medicine, Salford Royal NHS Trust, Salford, UK
Michael Stechman
General Surgery, University Hospital of Wales, Cardiff, UK
Philip Braude
3 CLARITY (Collaborative Ageing Research), North Bristol NHS Trust, Westbury on Trym, UK
Emma Mitchell
Medicine for Older People, North Bristol NHS Trust, Westbury on Trym, Bristol, UK
Alessia Verduri
Hospital Policlinico Modena, Modena, Italy
Kathryn McCarthy
3 Neurology, Swedish Medical Center, Englewood, Colorado, USA
Jonathan Hewitt
Geriatric Medicine, Cardiff University, Cardiff, UK
Charlotte Davey
Kiah Lunstone
Alice Cavenagh
Charlotte Silver
Thomas Telford
Rebecca Simmons
Dolcie Paxton
Francis Rickard
Mark Holloway
Head First (Assessment, Rehabilitation & Case Management) Limited, Hawkhurst, UK
James Hesford
Tarik Jichi
Norman Galbraith
Jenny Edwards
Carly Bisset
Ross Alexander
Abigail Ingham
Roxanna Short
Aine McGovern
Jemima Collins
Eilidh Bruce
Aberdeen Royal Infirmary
Alice Einarsson
Enrico Clini
Respiratory Diseases Unit, University of Modena and Reggio Emilia, Modena, Italy
Giovanni Guaraldi
Department of Infectious Diseases, Azienda Ospedaliero-Universitaria di Modena Policlinico di Modena, Modena, Italy
Introduction This protocol describes an observational study which set out to assess whether frailty and/or multimorbidity correlates with short-term and medium-term outcomes in patients diagnosed with COVID-19 in a European, multicentre setting.Methods and analysis Over a 3-month period we aim to recruit a minimum of 500 patients across 10 hospital sites, collecting baseline data including: patient demographics; presence of comorbidities; relevant blood tests on admission; prescription of ACE inhibitors/angiotensin receptor blockers/non-steroidal anti-inflammatory drugs/immunosuppressants; smoking status; Clinical Frailty Score (CFS); length of hospital stay; mortality and readmission. All patients receiving inpatient hospital care >18 years who receive a diagnosis of COVID-19 are eligible for inclusion. Long-term follow-up at 6 and 12 months is planned. This will assess frailty, quality of life and medical complications.Our primary analysis will be short-term and long-term mortality by CFS, adjusted for age (18–64, 65–80 and >80) and gender. We will carry out a secondary analysis of the primary outcome by including additional clinical mediators which are determined statistically important using a likelihood ratio test. All analyses will be presented as crude and adjusted HR and OR with associated 95% CIs and p values.Ethics and dissemination This study has been registered, reviewed and approved by the following: Health Research Authority (20/HRA1898); Ethics Committee of Hospital Policlinico Modena, Italy (369/2020/OSS/AOUMO); Health and Care Research Permissions Service, Wales; and NHS Research Scotland Permissions Co-ordinating Centre, Scotland. All participating units obtained approval from their local Research and Development department consistent with the guidance from their relevant national organisation.Data will be reported as a whole cohort. This project will be submitted for presentation at a national or international surgical and geriatric conference. Manuscript(s) will be prepared following the close of the project.